Explor Drug Sci EDS Exploration of Drug Science 2836-7677 Open Exploration Publishing 10.37349/eds.2026.1008153 1008153 Correction Correction: Exploring s-triazine derivatives as anticancer agents https://orcid.org/0000-0003-1282-5838 Sharma Anamika 1 * https://orcid.org/0000-0002-7988-7358 Shawish Ihab 2 https://orcid.org/0000-0001-5632-2293 Kumar Ashish 1 3 https://orcid.org/0000-0001-8521-9172 de la Torre Beatriz G. 3 https://orcid.org/0000-0002-8946-0462 Albericio Fernando 1 4 * https://orcid.org/0000-0002-3951-2754 El-Faham Ayman 5 6 * 1Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4000, South Africa 2Department of Math and Sciences, College of Humanities and Sciences, Prince Sultan University, Riyadh 11586, Saudi Arabia 3School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa 4Department of Inorganic and Organic Chemistry, University of Barcelona, 08193 Barcelona, Spain 5Department of Basic Medical Sciences, College of Medicine, Dar Al Uloom University, Riyadh 11512, Saudi Arabia 6Department of Chemistry, Faculty of Science, Alexandria University, Alexandria 21321, Egypt *Correspondence: Anamika Sharma, Sharmaa@ukzn.ac.za Fernando Albericio, Albericio@ukzn.ac.za. Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4000, South Africa Ayman El-Faham, Department of Basic Medical Sciences, College of Medicine, Dar Al Uloom University, Riyadh 11512, Saudi Arabia. ayman.a@dau.edu.sa 2026 02 03 2026 4 1008153 © The Author(s) 2026. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Correction to “Exploring s-triazine derivatives as anticancer agents” by Sharma A, Shawish I, Kumar A, de la Torre BG, Albericio F, El-Faham A. Explor Drug Sci. 2026;4:1008149. DOI: 10.37349/eds.2026.1008149

The authors have recognized an error in the published paper:

Figure 6 inaccurately gives the synthesis pathway and is replaced here with the corrected figure. The corrected figure clearly depicts a two-step synthesis pathway from the primary alcohol to the target heterocycle, compound 4. The corrected version of the figure is provided below.

MW-assisted synthesis of s-triazine derivatives (4). MW: microwave irradiation.

This correction does not affect the scientific content, interpretation of the results, or the conclusions of the paper. The authors apologize for any inconvenience caused to the readers by this error.

The original uncorrected PDF can be accessed from https://www.explorationpub.com//uploads/Article/A1008149/1008149.pdf